Abstract
Cocaine produces an array of neuropsychiatric states, and the violently agitated patient is perhaps the most dramatic ED presentation caused by this drug. This person typically arrives with a multitude of personnel who are attempting physical control. There is an appearance of incredible strength, but this may reflect an indifference to pain; the risk of physical harm to both caregivers and the patient is significant. The patient is delusional, paranoid, and often overtly psychotic. This state does not clearly relate to cocaine dosage, blood level [21], route of administration, or frequency of use. It does not seem to be precipitated by adulterants or concomitant use of other drugs, with the possible exception of alcohol; the role of cocaethylene.
While there is an increasing rate of use among young adults in all western countries over the past years (Fig. 42), more often, the combination of cocaine with alcohol is being advertised as this allegedly results in a prolongation of effects. Some 99% of contemporary Western users mix cocaine and ethyl alcohol. Cocaine and alcohol combine to be metabolized to another hugely reinforcing compound, cocaethylene. Coca-use only really took off in the West when it was blended with an alcoholic beverage. However, such combination is substantially more toxic than either substance on their own. For instance, about twelve million Americans combine ethanol with cocaine to produce a pronounced and prolonged euphoria. However it is known that the combination of these two drugs is substantially toxic. This may be a result of cocaethylene, detected in the serum of emergency patients. Cocaethylene is a cocaine metabolite, formed in the liver only in the presence of ethanol [9]. Being pharmacologically active it depresses the myocardium causing cardiotoxicity [22].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003;72:169–82.
Wetli CV, Fishbain DA. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci. 1985;30:873–80.
Henning RJ, Wilson LD. Cocaethylene is as cardiotoxic as cocaine but is less toxic than cocaine plus ethanol. Life Sci. 1996;59:615–27.
Fowler JS, Volkow ND, Logan J, McGregor RR, Wang GF, Wolf AP. [11C]cocaine phrmaciokinertics in human brain and heart. Synapse. 1992;12:228–35.
Cami J, Farré M, González ML, Segura J, de la Torre R. Cocaine metabolism in humans after use of alcohol. Clinical and research implications. Recent Dev Alcohol. 1998;14:437–55.
Landry MJ. An overview of cocethylene, an alcohol-derived psychoactive, cocaine metabolite. J Psychoactive Drugs. 1992;24:273–6.
Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88:325–31.
Om A. Cardiovascular complications of cocaine. Am J Med Sci. 1992;303:333–9.
Levis JT, Garmel GM. Cocaine-associated chest pain. Emerg Med Clin North Am. 2005;23:1083–103.
Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006;24:103–14.
Eichhorn EJ, Peacock E, Grayburn PA, et al Chronic cocaine abuse is associated with accelerated atherosclerosis in human coronary arteries. J Am Coll Cardiol. 1992;19:105A.
Mouhaffel AH, Madu EC, Satmary WA, Fraker TD. Cardiovascular complications of cocaine. Chest. 1995;107:1426–34.
Levis JT, Garmel GM. Cocaine-associated chest pain. Emerg Med Clin North Am. 2005;23:1083–103.
Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med. 1994;1:330–9.
Anderson JL, Adams CD, Antman EM, et al ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1–e157.
Brogan WC, Lange RA, Kim AS, et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18:581–6.
Hollander JE, Hoffman RS, Gennis P, et al Nitroglycerin in the treatment of cocaine associated chest pain–clinical safety and efficacy. J Toxicol Clin Toxicol. 1994;32:243–56.
Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267–72.
Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med. 2003;21:39–42.
Baumann BM, Perrone J, Hornig SE, et al. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med. 2000;7:878–85.
Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Arch Intern Med. 1990;112:897–903.
Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006;24:103–14.
Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med. 1992;327:361.
Hollander JE, Hoffman RS, Gennis P, Fairweather P, Feldman JA, Fish SS, et al. Cocaine-associated chest pain: one year follow-up. Acad Emerg Med. 1995;2:179–84.
Hollander JE, Thode HC, Hoffman RS. Chest discomfort, cocaine and tobacco. Acad Emerg Med. 1995;2:238.
Welch RD, Todd K, Krause GS. Incidence of cocaineassociated rhabdomyolysis. Ann Emerg Med. 1991;20:154–7.
Green R, Kelly KM, Gabrielson T, Levine SR, Vanderzant C. Multiple intracerebral hemorrhages after smoking “crack” cocaine. Stroke. 1990;21:957–62.
Levine SR, Brust JCM, Futrell N, Ho KL, Blake D, Millikan CH, et al Cerebrovascular complications of the use of the “crack” form of alkaloidal cocaine. N Engl J Med. 1990;323:699–704.
Westover AN, McBride S, Haley R. Stroke in young adults who abuse amphetamines or cocaine. A population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64:495–592.
Schindler CW. Cocaine and cardiovascular toxicity. Addict Biol. 1996;1:31–47.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media B.V.
About this chapter
Cite this chapter
Freye, E. (2009). Special Pathologies in Chronic Cocaine Use. In: Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2448-0_11
Download citation
DOI: https://doi.org/10.1007/978-90-481-2448-0_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2447-3
Online ISBN: 978-90-481-2448-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)